Cargando…
Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases
BACKGROUND: We assessed racial/ethnic disparity in hepatocellular carcinoma (HCC) incidence among men with type 2 diabetes (T2D) but without chronic liver diseases (CLD), and whether metformin use modified the disparity. METHODS: Study cohort: the nationwide Veterans Administration Health Care Syste...
Autores principales: | Wang, Chen‐Pin, Kuhn, John, Shah, Dimpy P., Schmidt, Susanne, Lam, Yui‐Wing F., MacCarthy, Daniel, Tenner, Laura, Ramirez, Amelie G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558591/ https://www.ncbi.nlm.nih.gov/pubmed/30993905 http://dx.doi.org/10.1002/cam4.2142 |
Ejemplares similares
-
Gastric adenocarcinoma burden and late‐stage diagnosis in Latino and non‐Latino populations in the United States and Texas, during 2004–2016: A multilevel analysis
por: Long Parma, Dorothy, et al.
Publicado: (2021) -
Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019) -
Disparities in telemedicine during COVID‐19
por: Qian, Alexander S., et al.
Publicado: (2022) -
Cancer survival disparities by health insurance status
por: Niu, Xiaoling, et al.
Publicado: (2013) -
Geographical disparities in human papillomavirus herd protection
por: Berenson, Abbey B., et al.
Publicado: (2020)